Biologic Therapies for Wound Care: Technologies and Global Markets

May 2022| BIO228A| BCC Publishing

Report Highlights

The global market for wound care biologics is estimated to increase from $2.2 billion in 2021 to $3.4 billion by 2026, at a compound annual growth rate (CAGR) of 9.3% during the forecast period of 2021-2026.

Report Includes

  • 23 data tables and 44 additional tables
  • An up-to-date overview of the global markets for wound care biologics within the industry
  • Analyses of the global market trends, with historic revenue (sales) data for 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Characterization and quantification of the market potential for wound care biologics, and market size estimation and forecast by product type, composition, application, end user vertical, and geographic region
  • Description of the integumentary system, wound classifications and wound healing process, and discussion on ECM composition and its importance in skin wound healing
  • Insight into the recent government regulations, reimbursement procedures, technological updates, 510 (K) approvals, and active clinical trials in wound care biologics that can shape the future marketplace
  • In-depth information (facts and figures) concerning market drivers, challenges and issues, and other macroeconomic forces influencing the progress of this market
  • Market share analysis of the key companies operating in the industry and Porter’s five forces analysis and their impact on the global market for wound care biologics
  • Descriptive company profiles of major global players, including AlloSource, Bioventus LLC, BioTissue Inc., Integra LifeSciences Corp., MiMedx, Stryker Corp., and Smith & Nephew, Plc.

Report Scope

This report studies the global market for wound care biologics. It describes different types of wound care biologics, including cellular and/or tissue-based products (CTPs), skin substitutes and topical agents, and their current and historical market revenues.

Skin substitutes are categorized into acellular and cellular composition, as well as biologic and bioengineered materials. Biologic skin substitutes are categorized into allografts and acellular animal derived tissue-based products or xenografts. Bioengineered skin substitutes are categorized into cellular and acellular or biosynthetic.

This report also studies applications for biologics in the care of chronic wounds and acute wounds. The market for chronic wounds includes venous leg ulcers, diabetic foot ulcers, pressure ulcers, and arterial and other ulcers. The market for acute wounds includes surgical and traumatic wounds and burns. An in-depth analysis of the market includes historical data and market projections based on sales by product type, application, end user and region. The report provides discusses the competitive landscape, key competitors and their respective market shares.

The scope of this report does not include biologics used for soft tissue reinforcement during plastic and reconstructive surgery. Such surgery is performed to treat structures of the human body that are affected aesthetically or functionally due to defects and abnormalities.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $1.8 billion
Market size forecast $3.4 billion
Growth rate CAGR of 9.3% from 2021 to 2026
Units considered $ Millions
Segments covered Type, Application, End User
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Sweden, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Russia, Japan, China, India, Australia, South Korea, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa
Key Market Drivers
  • Favorable Global Demographics and Aging Population
  • Greater Incidence of Non-Communicable/Chronic Diseases
  • Increasing Acceptance of Regenerative Technologies and Protocols for Complex Wound Treatment
  • Increasing Technology Innovations and New Product Developments
  • Improving Reimbursement Environment
Companies studied
  • 3M
  • ALLERGAN AESTHETICS
  • ALLOSOURCE
  • AROA BIOSURGERY LTD.
  • AZIYO BIOLOGICS
  • BIOTISSUE INC.
  • BIOVENTUS
  • CONVATEC GROUP PLC
  • COOK BIOTECH
  • INTEGRA LIFESCIENCES
  • MALLINCKRODT PLC
  • MIMEDX
  • MTF BIOLOGICS
  • ORGANOGENESIS HOLDINGS INC.
  • SKYE BIOLOGICS HOLDINGS LLC.
  • SMITH & NEPHEW PLC
  • STIMLABS LLC.
  • STRYKER CORP.
  • ZIMMER BIOMET

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Biologic Therapies for Wound Care: Technologies and Global Markets130Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background8Free
Chapter- 4: Market Dynamics10Free
Chapter- 5: Market Breakdown by Technology Type23Free
Chapter- 6: Market Breakdown by Application16Free
Chapter- 7: Market Breakdown by Region12Free
Chapter- 8: Market Breakdown by End User3Free
Chapter- 9: Regulatory Structure and New Product Developments11Free
Chapter- 10: Competitive Landscape6Free
Chapter- 11: Company Profiles31Free
Chapter- 12: Appendix: Acronyms1Free
Biologic Therapies for Wound Care: Technologies and Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS